Your session is about to expire
← Back to Search
Centanafadine for ADHD
Study Summary
This trial is to see if a new medicine for ADHD is safe and tolerated by kids.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My ADHD symptoms score is 28 or higher.You have a score of 4 or higher on a test that measures symptoms of attention deficit hyperactivity disorder (ADHD).You have certain mental health conditions like Tourette's Disorder, severe anxiety, panic disorder, conduct disorder, psychosis, post-traumatic stress disorder, bipolar disorder, autism spectrum disorder, binge eating disorder, anorexia, bulimia, oppositional defiant disorder, or severe obsessive-compulsive disorder. If you have major depressive disorder, you either had treatment within the last 6 months or may require treatment during the trial.I am between 4 and 17 years old.I am 4 or 5 years old and need medication for my severe condition, despite not trying psychotherapy.I finished a 6-week ADHD treatment trial and my doctor thinks I could benefit from more.I am between 4 and 17 years old.I am 4 or 5 years old and need medication for my condition, despite psychotherapy.You have a history of suicide attempts or current thoughts of harming yourself.I have been diagnosed with ADHD according to DSM-5 criteria.I have been diagnosed with ADHD according to DSM-5 criteria.I am not pregnant or breastfeeding.You have a score of 4 or higher on the CGI-S-ADHD at baseline.I finished a 6-week ADHD treatment trial and my doctor thinks I could benefit from more.My body weight is less than 13 kg.My ADHD symptoms score is 28 or higher.I have recently started, stopped, or changed ADHD therapy.You have experienced skin reactions from taking medication before.
- Group 1: Centanafadine Hydrochloride
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Could you please inform me of the risks associated with taking Centanafadine Hydrochloride?
"Centanafadine Hydrochloride, which is currently in Phase 3 clinical trials, was given a safety rating of 3. This reflects the presence of some efficacy data as well as multiple rounds of supportive safety data."
Are geriatric patients accepted into this program?
"According to the information provided, patients that meet the age criteria of 4-17 years old are eligible for this trial. There are a total of 112 studies targeting people under 18 and 40 for those over 65."
To whom is this study available?
"Patients that have been diagnosed with attention deficit hyperactivity disorder and are between the ages of 4-17 may be accepted into this clinical trial. Currently, the study is looking to enroll around 700 patients."
Are people with the target condition eligible to participate in this research right now?
"Yes, this is an ongoing trial that was posted on February 24th, 2022 and last updated August 31st, 2022. The study will take place at a single site but 700 patients are needed for the clinical trial."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger